About RxSight, Inc.
https://www.rxsight.comRxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery.
CEO
Ronald M. Kurtz
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 75
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Needham
Buy
Morgan Stanley
Equal Weight
Wells Fargo
Equal Weight
UBS
Neutral
BTIG
Neutral
Piper Sandler
Neutral
Grade Summary
Showing Top 6 of 10
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:2.7M
Value:$26.13M
BLACKROCK INC.
Shares:2.4M
Value:$23.21M
MILLENNIUM MANAGEMENT LLC
Shares:2.19M
Value:$21.21M
Summary
Showing Top 3 of 174
About RxSight, Inc.
https://www.rxsight.comRxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $30.34M ▼ | $36.41M ▼ | $-9.82M ▲ | -32.35% ▲ | $-0.24 ▲ | $-8.95M ▲ |
| Q2-2025 | $33.64M ▼ | $39.19M ▲ | $-11.79M ▼ | -35.04% ▼ | $-0.29 ▼ | $-10.96M ▼ |
| Q1-2025 | $37.9M ▼ | $39M ▲ | $-8.19M ▼ | -21.61% ▼ | $-0.2 ▼ | $-7.38M ▼ |
| Q4-2024 | $40.21M ▼ | $37.42M ▲ | $-5.94M ▲ | -14.77% ▼ | $-0.15 ▲ | $-5.4M ▼ |
| Q3-2024 | $45.41M | $34.45M | $-6.34M | -13.96% | $-0.16 | $-5.18M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $227.52M ▲ | $308.53M ▼ | $32.56M ▲ | $275.97M ▼ |
| Q2-2025 | $227.49M ▼ | $309.01M ▼ | $31M ▼ | $278.01M ▼ |
| Q1-2025 | $229.34M ▼ | $313.04M ▼ | $33.73M ▼ | $279.32M ▼ |
| Q4-2024 | $237.22M ▲ | $318.56M ▲ | $37.33M ▲ | $281.24M ▲ |
| Q3-2024 | $237.12M | $310.47M | $33.21M | $277.26M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-9.82M ▲ | $-1.19M ▲ | $-9M ▼ | $-530K ▼ | $-10.72M ▼ | $-1.77M ▲ |
| Q2-2025 | $-11.79M ▼ | $-4.38M ▲ | $14.65M ▼ | $2.06M ▲ | $12.36M ▲ | $-5.91M ▲ |
| Q1-2025 | $-8.19M ▼ | $-8.83M ▼ | $20.86M ▲ | $-735K ▼ | $11.29M ▲ | $-9.41M ▼ |
| Q4-2024 | $-5.94M ▲ | $-4.26M ▼ | $1.32M ▲ | $2.98M ▲ | $-14K ▲ | $-5.11M ▼ |
| Q3-2024 | $-6.34M | $730K | $-9.26M | $798K | $-7.72M | $-373K |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 L D D | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ | $0 ▼ |
 Service Warranty Service Contracts And Accessories | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
CEO
Ronald M. Kurtz
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 75
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Needham
Buy
Morgan Stanley
Equal Weight
Wells Fargo
Equal Weight
UBS
Neutral
BTIG
Neutral
Piper Sandler
Neutral
Grade Summary
Showing Top 6 of 10
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:2.7M
Value:$26.13M
BLACKROCK INC.
Shares:2.4M
Value:$23.21M
MILLENNIUM MANAGEMENT LLC
Shares:2.19M
Value:$21.21M
Summary
Showing Top 3 of 174